Risk of malignancy in rheumatoid arthritis patients initiating biologics: an historical propensity score matched cohort study within the French nationwide healthcare database

Risk of malignancy in rheumatoid arthritis patients initiating biologics: an historical propensity score matched cohort study within the French nationwide healthcare database

Objective To compare the risk of malignancy between patients with rheumatoid arthritis (RA) initiating their first biological disease-modifying antirheumatic drug (bDMARD) and those continuing conventional synthetic DMARDs (csDMARDs).Methods Nine-year historical Propensity Score (PS) matched cohort...

Full description

Bibliographic Details
Main Authors: Bruno Fautrel, Xavier Mariette, Yann De Rycke, Florence Tubach, Johann castaneda, Raphaele Seror, Sandrine Pinto, Alexandre Lafourcade
Format: Article
Language:English
Published: BMJ Publishing Group 2022-11-01
Series:RMD Open
Online Access:https://rmdopen.bmj.com/content/8/2/e002139.full

Internet

https://rmdopen.bmj.com/content/8/2/e002139.full

Similar Items